Clinical Trial: [99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression

U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07275463) titled '[99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression' on Nov. 28.

Brief Summary: The study should evaluate the [99mTc]Tc-DB8 accumulation in primary tumour of breast cancer patients with positive and negative estrogen receptor expression

Study Start Date: Oct. 01

Study Type: INTERVENTIONAL

Condition: Primary Breast Cancer

Intervention: DRUG: [99mTc]Tc-DB8

One single injection of [99mTc]Tc-DB8, followed by SPECT/CT imaging 2 hours after the injection

Recruitment Status: ENROLLING_BY_INVITATION

Sponsor: Tomsk National Research Medical Center of the Russian Academ...